Home » Newsletters » BioWorld Asia

BioWorld Asia

July 1, 1998

View Archived Issues

Tm Raises C$14M For Programs Using 'Second Genetic Code'

Cerebrus Forms Joint Venture With Wolfson Institute For CNS

EU Climate Continues To Worsen For Biotech

Sugar-Coated Bioweapon Shows Resilience Of Anthrax

Cambridge Antibody Pays US$11M For Polysome Display Firm

EC Supports US$150M For Biotech Projects

Public Urges French Officials To Monitor Transgenic Plants

Peptech Shares Fluctuate With Veterinary Drug Approval

Enzacta Takes Different Approach To Cancer Chemotherapies

Cerep Licenses Gene Profile System From Xenometrix

Israeli PM Backs Participation In European R&D Program

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.